Loading...
Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Table of Content

    Volume 12 Issue 11
    26 November 2007
    To identify and evaluate causal relationship between drug and single adverse event
    YANG Jin-bo
    2007, 12(11):  1201-1204. 
    Asbtract ( 64 )   PDF (175KB) ( 170 )  
    References | Related Articles | Metrics
    It is very important in safety evaluation to determining causal relationship between drugs and adverse events. Supported by the available literatures, the purpose of this review is to introduce some methods to identify and assess simple adverse event, and some challenges remain need to face to.
    PPAR δ and its role in the metabolic syndrome
    YANG Ming, LIU Zhao-qian
    2007, 12(11):  1205-1210. 
    Asbtract ( 91 )   PDF (221KB) ( 147 )  
    References | Related Articles | Metrics
    Obesity, insulin resistance, dyslipidemia, hypertension and glucose intolerance are some major characteristics of metabolic syndrome. PPARδ is a novel discovered isoform of PPARs family with abundant ligands. Activation of PPARδ can enhance fatty acid oxidation and energy uncoupling in adipose tissue and muscle, suppress macrophage-derived inflammation, and improve both hypertriglyceridemia and insulin resistance. These physiological functions of PPARδ imply that it may be a therapeutic target for the treatment of metabolic syndrome via controlling body weight, improving insulin sensitivity, and ameliorating the symptom of atherosclerosis.
    Cardioprotective function of brain natriuretic peptide in patients with heart failure
    ZHU Xiao-qin, HONG Hua-shan
    2007, 12(11):  1211-1215. 
    Asbtract ( 73 )   PDF (195KB) ( 52 )  
    References | Related Articles | Metrics
    Heart failure(HF) is the end stage of many cardiovascular diseases. Both the neurohumor overactivation and ventricular remodeling are the critical pathophysiological processes of HF. It has been demonstrated that the serum level of brain natriuretic peptide (BNP) is elevated obviously in HF patients. As a circulatory hormone, BNP is mainly produced in cardiac ventricle. Through the natriuretic receptor (NPR)-cyclic guanosine monophosphate(cGMP) pathway, BNP performs the properties of natriuresis, diuresis, vasodilatation, enhancing vagal reflex and inhibiting sympathetic activity, which can improve the hemodynamic of HF without activation of plasma renin. It has been reported that BNP has effects of antihypertrophic and antifibrotic and plays a role in the antiventricular remodeling. In a word, BNP plays an important role of cardioprotection in the development and prognosis of HF though the local autocrine and /orparacrine ways.
    Progress in pharmacokinetic of transdermal drugs
    WANG Hui
    2007, 12(11):  1216-1220. 
    Asbtract ( 131 )   PDF (188KB) ( 671 )  
    References | Related Articles | Metrics
    In this paper, some study methods of pharmacokinetic, the explanation ways of data and experimental methods of transdermal therapeutic system(TTS) were described. The advancement of modern science accelerates the development of pharmacokinetic of TTS and makes more progress in this field.
    Progress of signal transduction pathway of gastrin stimulating proliferation of colorectal carcinoma cells
    ZHAO Ying-chun, WU Pei
    2007, 12(11):  1221-1225. 
    Asbtract ( 62 )   PDF (186KB) ( 74 )  
    References | Related Articles | Metrics
    Recent studies indicate that there are expressions of gastrin and its receptors in the tissue and cell line of colorectal cancer. Gastrin stimulates the proliferation of colorectal carcinoma as well as inhibits the apoptosis of colorectal carcinoma so as to promote the growth and invasion of colorectal carcinoma via a series of signal transduction pathways induced by its specific receptors. To inhibit the abnormally active signal transduction pathways that stimulate the proliferation of colorectal carcinoma will provide a new effective measure for the prevention and management of colorectal carcinoma. But the accurate signal transductions are not clear and need further research.
    ATR12181 vaccine in reducing microalbuminuria of spontaneously hypertensive rat
    WEI Fen, LIAO Yu-hua, LI Liu-dong, ZHOU Zi-hua, WANG Bin, WANG Min
    2007, 12(11):  1226-1230. 
    Asbtract ( 77 )   PDF (274KB) ( 169 )  
    References | Related Articles | Metrics
    AIM: To evaluate effect of active immunization with peptide ATR12181 from the extracellular parts of AT1 receptor on reducing microalbuminuria of SHRs. METHODS: SHRs and Wistar rats were immunized actively by ATR12181, the synthesized peptide from the extracellar part of AT1 receptor. Another SHR group was given Losartan (10 mg·kg-1·d-1) orally by gastric gavage once a day in morning. The specific serum antibody titer and 24h urinary albumin excretion were detected by ELISA, the Systolic Blood Pressure(SBP) of SHR was measured consecutively, and the mRNA of AT1R, cfos, c-jun in kidney were measured by RT-PCR. RESULTS: The antibodies to ATR12181 were detected both in immulized SHRs (SHR-I) and WISTAR rats (WISTAR-I). At 20 weekends, SHR-I group got a lower SBP (145 mm Hg±8 mm Hg) than SHR-C group (197 mm Hg±8 mm Hg),but no significant difference compared with the SHR-L group (139 mm Hg±17 mm Hg, P>0.05). The SBP of WISTAR-I group was normal (116 mm Hg±6 mm Hg). 24 h urinary albumin excretion both in SHR-I group and SHR-L group were significantly lower than that of SHR-C group (P< 0.05); The mRNA of the AT1R, c-fos, c-jun were significantly lower in SHR-I group and SHR-L group. CONCLUSION: ATR12181 vaccine may produce high titer antibody, that reduce the blood pressure, and decrease urinary protein excretion in SHR.
    Pharmacokinetics of salvianolic acid B after intravenous administration in rats
    MA Le, REN Wei-chao, DONG Jing, HE Hui, CHEN Xi-jing, WANG Guang-ji
    2007, 12(11):  1231-1236. 
    Asbtract ( 77 )   PDF (244KB) ( 91 )  
    References | Related Articles | Metrics
    AIM: To establish an HPLC mehod for the analysis of pharmacokinetics of salvianolic acid B in rats. METHODS: The biological samples were extracted with acetic ether. The chromatographic conditions were as follows: Hypersil ODS column (200 mm ×4.6 mm,5μm)was used. The mobile phase was acetonitrile-water (with Ammoniom Acetate 0.25 mol/L)(25:75,v/v) at a flow-rate of 1.0 mL min,and the detection wave length was set at 328 nm. RESULTS: Salvianolic acid B was injected intravenously at doses of 1.6,3.2,6.4 mg/kg. The terminal elimination half-life(t 1 2)of αphase and β phase was (3.1±0.1)min and (31.5±3.2) min. The extents of excrement,urine and biliary excretion of salvianolic acid B were 1.43 %±0.90 %, 0.77 %±1.01 % and 8.82 %±4.11 %.The tissue concentration of salvianolic acid B was as followed in order: Cheart> Cliver>Clung>Cintestine>Ckidney>Cspleen>Cstomach .The plasma protein binding rate of salvianolic acid B in human plasma and in rat was similar(89.2 %±1.8 %, 92.5 %±1.5 %).CONCLUSION: The method is accurate,stable and reliable,and can be used for the investigation of salvianolic acid B in pharmacokinetics research. Salvianolic acid B eliminates fast and it shows a high plasma protein binding rate,the mainly excretion way of salvianolic acid B is from biliary.
    Anti-oxidative properties of Suyu capsule that ameliorates the stress-induced chronic depressive-behavior in rats
    HUANG Zhen, MAO Qing-qiu
    2007, 12(11):  1237-1240. 
    Asbtract ( 69 )   PDF (168KB) ( 103 )  
    References | Related Articles | Metrics
    AIM: To study the anti-oxidative properties of Suyu capsule that ameliorates the stress-induced chronic depressive-behavior in rats. METHODS: 48 male SD rats were separated randomly into 6 groups including the control group, the model group, three suyu capsule groups(the doses were 22.8, 11.4, 5.7 g/kg respectively) and Anafranil(0.02 g/kg). The model was established by separation and chronic unpredictable mild stimulation. Mensurating the increased weight, cane sugar water consumption and residence time, crossing score, rearing score by open-field; the activity of superoxide dismutase (SOD),the content of malondialdehyde(MDA) in serum and cerebra of rats were mensurated, too. RESULTS: Suyu capsule could improve the increased weight, cane sugar water consumption and improve the behavioral impairment obviously in chronic unpredictable stress depression rats; Suyu capsule also increased the activity of SOD and decrease the content of MDA in serum and cerebra of rats. ONCLUSION: Suyu capsule can ameliorate the behaviour of chronic unpredictable stressed rats. The inhibition of lipid peroxidation and the scavenging of free radical may account for the observed antidepressant effects.
    Effects of extract of Sonchus oleraceus on cardiovascular protection
    MU Yan-ling, XIE Yan-ying, ZHOU Ling, XU Shu-lan, HU Zhi-li, WANG Fu-wen
    2007, 12(11):  1241-1244. 
    Asbtract ( 49 )   PDF (165KB) ( 48 )  
    References | Related Articles | Metrics
    AIM: To observe the cardiovascular protective effects of extract from Sonchus oleraceus. METHODS: Several experiments including hypoxia experiment, the survival test of hungry mice, acute myocardial ischemia, and electrical stimulation of thrombosis model in rats were used to evaluate the pharmacy activity of extract of Sonchus oleraceus. RESULTS: Extract of Sonchus oleraceus markedly prolonged the living time of the fasting, hypoxia experimetal mice, the formation time of carotid artery thrombosis, decreased blood viscosity shear rate (compared with control, P<0.01),prevent myocardial ischemia caused by hypophysin. CONCLUSION: Extract of Sonchus oleraceus can prolong formation time of carotid artery thrombosis, anti-myocardial ischemia and then protect cardiovascular.
    Effects of the original constituent of Liu-wei Di-huang pill morroniside on the proliferation and differentiation of rat preadipocyte
    DAI Bing, XIAO Zi-zeng, LIU Lei, LENG Wang, MEI Jun, ZOU Shuang-hua
    2007, 12(11):  1245-1249. 
    Asbtract ( 80 )   PDF (192KB) ( 92 )  
    References | Related Articles | Metrics
    AIM: To study the concentration of morroniside in rat serum after oral administration of Liu-wei Di-huang pills(LDP), to investigate the effect of morroniside on proliferation and differentiation of rat preadipocytes. METHODS: The determination of morroniside concentration in rat serum was taken on RP-HPLC after taking LDP, rat preadipocytes were primary cultured,its proliferation was detected by MTT method,its differentiation was tested by Oil Red O staining. RESULTS: The linear range of morroniside was 250-2 000 ng (r = 0.9991), the average recovery was 95.27 %;morroniside of 8.5-68.0 μg/mL could stimulate rat preadipocyte proliferation,inhibited its lipid accumulation. CONCLUSION: Morroniside could be one of the original constituents migrating to blood of LDP; the method combined pharmacodynamics with determination and isolation of constituents migrating to blood could be helpful for illuminating the active components and mechanism of LDP.
    Immunoreactivity and neutralization against king cobra venom of antiking cobra venom IgY
    WANG Gui-ping, LIU Xin-yan, ZHU Liu, YU Qing-sheng
    2007, 12(11):  1250-1254. 
    Asbtract ( 91 )   PDF (182KB) ( 181 )  
    References | Related Articles | Metrics
    AIM: To explore the immunoreactivity and neutralization against king cobra venom of anti-king cobra venom IgY. METHODS: The anti-king cobra venom IgY was developed by thiophilic adsorption chromatography. The biological activity of anti-king cobra venom IgY was detected by indirect ELISA. In vivo and in vitro protective experiments in mice were used for evaluating the neutralization against king cobra venom of anti-king cobra venom IgY. RESULTS: The anti-king cobra venom IgY developed by thiophilic adsorption chromatography showed good biological activity and immunoreactivity,and it also neutralized king cobra venom well. A dose of 6 mg/kg anti-king cobra venom IgY could neutralize 4 LD50(about 1.6 mg/kg)of king cobra venom in vitro,and neutralize 3 LD50(about 1.2 mg/kg)of king cobra venom in vivo. CONCLUSION: The anti-king cobra venom IgY can neutralize king cobra venom,and the present study provides experiment data for further study of antiking cobra venom IgY.
    CYP3A1/2 and 2C9/10 in rat liver microsomes mediate 22α-and 24-hydroxylation of 18α-glycyrrhetic acid
    GAO Kai, WEI Yu, YANG Jing, DUAN Xu-hua
    2007, 12(11):  1255-1260. 
    Asbtract ( 65 )   PDF (262KB) ( 271 )  
    References | Related Articles | Metrics
    AIM: To identify the cytochrome P450 isoforms involved in 22 α-hydroxylation and 24-hydroxylation of 18α-glycyrrhetic acid (GA) in rat livers. METHODS: Kinetic analysis of the rates of formation of monohydroxylated metabolites of GA, including 22 α-hydro-GA and 24-hydro-GA, was performed using rat liver microsomes at substrate concentrations ranging from 25 to 200 μmol/L. Seven selective inhibitors or substrate probes specific for different CYP isoforms were applied for screening the isoform (s) responsible for mono-hydroxylated metabolism of GA hydroxylate. RESULTS: The formation of metabolites of GA depended on incubation time(10-40 min),substrate concentration (25-200 μmol/L) and microsome protein concentration (0.25-1.0 g/L). The kinetic behaviors of 22α-hydroxylation and 24-hydroxylation of GA were described well by a Michaelis-Menten equation [Vmax were (7.89±1.43) and (3.38±0.95) μmol·min-1·g-1,Km was (33.5±8.6) and (67.8±17.9) μmol/L, respectively]. Inhibition experiments showed that troleandomycin (6.25-100 μmol/L and erythromycin (15.7-250 μmol/L) as potent CYP3A1/2 inhibitors, reduced 22α-hydroxylation in a dose-dependent manner (the maximum inhibitory rates were 82.4 % and 45.7 %, respectively),while sulfaphenazole, which was an inhibitor towards 2C9/10 did not display significant inhibition. 22α-hydroxylation of GA correlated well with erythromycin N-demethylase activities (r =0.864, P<0.01, n =10). Sulfaphenazole (6.25-100 μmol/L) as potent CYP2C9/10 inhibitors, reduced 24-hydroxylation of GA in a dose-dependent manner, the maximum inhibitory rate was 69.5 %, while troleandomycin, which were inhibitors as CYP3A1/2 did not display significant inhibition. The 24-hydroxylation of GA did not correlate with erythromycin N-demethylase activities (r = 0.310, P> 0.05, n = 10). CONCLUSION: CYP3A1/2 and CYP2C9/10 in rat liver microsomes mediate the 22α-hydroxylation and 24-hydroxylation of GA.
    Preventive effects of Ligustrazine on bone loss induced by Cyclophosphamide in male rats
    HE Kang, FENG You-hui, LIN Yu-hui
    2007, 12(11):  1261-1263. 
    Asbtract ( 73 )   PDF (133KB) ( 118 )  
    References | Related Articles | Metrics
    AIM: To observe the preventive effects of Ligustrazine (Lig) on bone loss induced by Cyclophsphamide (CY) in male rats. METHODS: Thirty 3-monthold Sprague-Dawley male rats were randomly divided into 3 groups. Rats in control group were treated by daily oral gavage with vehicle. Rats in other two groups were treated by either daily oral gavage with CY at 4.5mg·kg-1·d -1, or CY at 4.5 mg·kg-1·d -1 and Lig at 50 mg·kg-1·d-1 for 15 days. At the endpoint the right femoral was collected to determine bone weight, contents of calcium (Ca) and Hydroxyproline(Hyp). The number of leukocyte, the weight of thymus and spleen were determined, respectively. RESUITS: The contents of Ca and Hyp of humerus, number of leukocyte, weights of thymus and spleen in CY group were decreased when compared with those in control group, while those in Lig group were greater than those in CY group. CONCLUSION: Lig could prevent bone loss induced by CY in male rats.
    Effects of propofol on long-term potentiation of CA1 area in rat hippocampus in vivo
    WEI Hui-ming, YANG Yun-li, MA Wei-qing, YU Tao, LI Zhi-gui, LI Wen-feng
    2007, 12(11):  1264-1268. 
    Asbtract ( 71 )   PDF (206KB) ( 100 )  
    References | Related Articles | Metrics
    AIM: To study the effects of propofol on long-term potentiation (LTP) in the CA1 area of rat hippocampus in vivo and to elucidate the possible underlying mechanisms. METHODS: 63 pentobarbitone-anaesthetized rats were used to investigate the effects of propofol (20 mg/kg, i. p.) alone and with NMDA or AMPA receptor antagonists (APV or CNQX) on excitatory postsynaptic potential (EPSP) and LTP expression of the CA1 stratum radiatum of the rat hippocampus by using stereotaxic technology and extracellular recording. RESULTS: Baseline EPSP amplitudes of all groups were stable. During treatment with propofol before high f requency stimulation (HFS),LTP amplitude was the same as that of control (P>0.05),whereas when given after HFS, propofol significantly lowered the amplitude of LTP compared with control (P<0.01). On the other hand, LTP could not be induced after treatment of propofol with APV, however, the amplitude of LTP increased transiently and decreased to baseline rapidly after treatment with propofol and CNQX (P<0.05). CONCLUSION: Propofol did not affect the induction of LTP which is dependent on NMDA receptors in the CA1 area of the rat hippocampus but propofol did inhibit the LTP maintenance, which may be attributed to blockade of AMPA receptors but not to NMDA receptors.
    Immunoloregulation effect of selenocarrageenan syrupus in mice
    WU Xin, ZHANG Chun-dong, DAI Min
    2007, 12(11):  1269-1273. 
    Asbtract ( 81 )   PDF (189KB) ( 159 )  
    References | Related Articles | Metrics
    AIM: To investigate the effects of selenocarrageenan syrupus on nonspecific immunity, humoral immunity, cell immmunity of immune suppressed mice with cyclophosphamide. METHODS: Intraperitoneal injecting cyclophosphamide(80 mg/kg, i. d.) in mice for 3 days to make immunity hypofunction mice model and given selenocarrageenan syrupus by gastric gavage for 30 days. We tested the mononuclear phagocyte englobement function, serum haemolysin, delayed hypersensitivity (DTH),interlukine-1, 2(IL-1, 2) activity and T, B lymphocyte proliferating function. RESULTS: High and medium dose(30, 10 μg/kg) of selenocarrageenan syrupus increased mononuclear phagocyte englobement function, T lymphocyte proliferating function and delayed hypersensitivit significantly. All 3 doses increased serum haemolysin, IL-1, 2 activity and B lymphocyte proliferating function significantly. CONCLUSIION: The results suggest that selenocarrageenan syrupus could promote the immunological function of immune suppressed mice.
    Pharmacokinetic study of synthesized thymosin alpha 1 in monkeys after intravenous administration
    WANG Li, MIAO Miao-miao, QIN Hong, WU Yong-jie, CUI Ming-xia, LU Li
    2007, 12(11):  1274-1278. 
    Asbtract ( 84 )   PDF (196KB) ( 92 )  
    References | Related Articles | Metrics
    AIM: To study pharmacokinetic property of synthesized thymosin alpha 1(sTα1) after intravenous (i. v.) injection to monkeys. METHODS: Competition ELISA analysis was used for detecting drug concentration in serum after i. v. administration of sTα1 in monkeys. Pharmacokinetic parameters were calculated by DAS software. RESULTS: Pharmacokinetic model of sTα1 after i. v. was consistent with two-compartment open model, and in accordance with first-order kinetic elimination. CONCLUSION: Pharmacokinetic model after i. v. of sTα1 is two-compartment open model, and in accordance with first-order kinetic elimination.
    Therapeutic effects of rh-bFGF on duodenal ulcers in rats and its preclinical safety evaluation
    LI Wen-guang, ZHANG Yan-xia, WU Yong-jie, GAO Ming-tang
    2007, 12(11):  1279-1282. 
    Asbtract ( 77 )   PDF (188KB) ( 103 )  
    References | Related Articles | Metrics
    AIM: To investigate the therapeutic effects of recombinant human basic fibroblast growth factor (rh-bFGF) on duodenal ulcers in rats and to evaluate its preclinical safety. METHODS: The duodenal ulcer was induced by cysteamine s. c. in rats. The acute and chronic toxicity was observed in mice and Beagle dogs. The chronic toxicity was investigated in rats and Beagle dogs for 90 days. RESULTS: In rats treated by rh-bFGF, the area of duodenal ulcerwas reduced, and the proliferation velocity of surface glandular epithelium of duodenal ulcer was increased significantly compared with that of control group. The ulcers entirely covered by epithelium were nearly 60 % in rh-bFGF treated groups as contrast to 13 % in famotidine group. The maximum tolerable dose of mice or Beagle dogs was more than 2 ×106AU/kg or 3.5 ×105AU/kg when rh-bFGF was given intravenously or orally, which was 4167 or 729 times of clinic dose, respectively. After treatment with rh-bFGF by mouth for 90 days, the appearance, general behavior, growth and development of rats and Beagle dogs were not affected. And the hematological and blood biochemical indices in rh-bFGF treated group had no obvious difference compared with those of control group. It also did not affect the haematogenesis function of bone marrow in rats and dogs. And the pathohistological change was not found in all organs of dogs and rats. CONCLUSION: The rh-bFGF obviously promotes the ulcer healing as well as glandular epithelium reconstruction of duodenal ulcers in rats. And there is no obviously acute and chronic toxicity reaction during this experiment.
    Study on the effect of anti-diabetes and cell protection of a new peptide S-8300
    HUANG Feng-jie, WU Wu-tong
    2007, 12(11):  1283-1287. 
    Asbtract ( 65 )   PDF (357KB) ( 107 )  
    References | Related Articles | Metrics
    AIM: The purpose of this study was to evaluate the effect of anti-diabetes and cell protection of a new peptide S-8300 on streptozotocin diabetic mice. METHODS: The apoptosis induced by streptozotocin (STZ) in the diabetic mice was tested through cytometer and TUNEL technology. The biological activity was measured by MTT assay with mouse insulinoma β-cell line (NIT-1) which was exposed to the toxins STZ. RESULTS: S-8300 obviously reduced the rate of apoptosis in injured pancreas induced by STZ and it could also protect the structure integrity and recover the damage of NIT-1 cell after exposed to the toxin of STZ. CONCLUSION: The hypoglycemic mechanism of the anti-apoptotic effect of S-8300 may be related with the protective activity anainst the apoptosis.
    Effects of the recombinant human growth hormone on recovery of nervous function with focal cerebral ischemia in rats
    LI Rong, LUO Chun-xia, CHI Lu-xiang
    2007, 12(11):  1288-1291. 
    Asbtract ( 63 )   PDF (246KB) ( 111 )  
    References | Related Articles | Metrics
    AIM: To investigate the effects of the recombinant human growth hormone (rhGH) on the recovery of nervous function with focal cerebral ischemia in rats. METHODS: The middle cerebral artery occlusion (MCAO) model was established by insertion of nylon thread in SD rats. The rhGH was given to the rats in the rhGH-treated group. The infarct size and recovery of nervous function were observed after MCAO. RESULTS: The infarct size in the rhGH-treated group (29±5) % was obviously smaller than that in the simple ischemia group (36±4) %.The recovery of nervous function in the rhGH-treated group was much better than that in the simple ischemia group. CONCLUSION: It is manifested that the rhGH can significantly reduce the injure of brain tissue and recover nervous function caused by cerebral infarction.
    Study on the effect of the Agkistrodon halys's venom-stimulated glucose uptake
    WANG Guo-guang, XU Min, DUAN Hai-feng, ZHANG Gen-bao
    2007, 12(11):  1292-1294. 
    Asbtract ( 86 )   PDF (162KB) ( 76 )  
    References | Related Articles | Metrics
    AIM: To investigate the effect of Agkistrodon halys's venom on stimulation glucose uptake and the effect of the Agkistrodon halys's venom on Akt activity in Hep G2 cells. METHODS: The Hep G2 cells were inoculated in the culture capsule. The Hep G2 cells were randomized into four groups(n =6 wells each): Control group, insulin group, Agkistrodon halys's venom group and insulin with Agkistrodon halys's venom group. Scintillation was used to detect 2-DG uptake in Hep G2 cells. The phosphorylation of Akt was tested using western blot. RESULTS: Compared with control cells, Agkistrodon halys's venom significantly stimulated the glucose uptake (P<0.01) and increased the insulin-stimulated glucose uptake(P<0.01) in Hep G2 cells. The venom evidently enhanced the activity of Akt inHep G2 cells. CONCLUSION: The venom stimulates the glucose uptake and increases the insulin-stimulated glucose uptake in Hep G2 cells, is a potential anti-hyperglycemic agent.
    Noninvasive functional imaging techniques: positron emission tomography (PET),magnetic resonance spectroscopy (MRS),dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
    Ruediger E. Port
    2007, 12(11):  1295-1298. 
    Asbtract ( 71 )   PDF (309KB) ( 59 )  
    References | Related Articles | Metrics
    In the pharmaceutical industry, there is currently increasing interest in noninvasive functional imaging techniques as potential early indicators of drug effects in patients. PET allows one to monitor absolute concentrations of radiolabeled drugs and metabolites, or of ligands to specific receptors, in tissues, and to visualize their distribution three-dimensionally. MRS is capable of monitoring metabolic conversions in vivo without labeling. DCE-MRI shows the distribution of small-molecular, hydrophilic weight contrast agents between blood plasma and interstitial space in tissue in real time and can be used to detect effects of antivascular or anti-angiogenic compounds.
    Design of a clinical trial of non-inferiority for treating acute bacterial infections and its quantitive analysis
    HE Ying-chun, YANG Juan, XU Ling, LV Ying-hua, LIU Hong-xia, SUN Rui-yuan, ZHENG Qingshan
    2007, 12(11):  1299-1305. 
    Asbtract ( 82 )   PDF (250KB) ( 90 )  
    References | Related Articles | Metrics
    AIM: To design a clinical trial of non-inferiority for treating acute bacterial infections by an example and quantitively analyze the results. METHODS: A randomized, double-blind, multicenter, parallel controlled, and non-inferiority study was designed to compare the efficacy and safety of antofloxacin hydrochloride (200 mg, qd) and levofloxacin (200 mg, q12 h) (n =360). The oral administration lasted 7-14 days.The main end point was clinical efficacy rates. The margin of non-inferiority was 0.15 (15 %). RESULTS: After 7-14 days of treatment, no significant difference was found between the two groups either in the efficacy rate (antofloxacin hydrochloride: 95.1 %, Levofloxacin: 96.6 %, treatment difference,-0.015; 95 % confidence interval [CI] for the difference,-0.045 to 0.015) or the incidence of adverse reactions (antofloxacin hydrochloride: 8.1 %, levofloxacin: 8.1 %). CONCLUSION: Antofloxacin hydrochloride is non-inferior to levofloxacin, and well tolerated in the treatment of acute bacterial infections.
    Multilevel Poisson regression models in crossover clinical trails
    CHEN Jia-hui, FU Chun-feng, ZHAO Yang, CHEN Feng
    2007, 12(11):  1306-1310. 
    Asbtract ( 102 )   PDF (193KB) ( 128 )  
    References | Related Articles | Metrics
    AIM: To find the method of analyzing counting data from multi-center crossover clinical trails. METHODS: Multilevel Poisson regression model was fitted with the repeated-measurements as the first level,stage as the second level and patient as the third level. RESULTS: Multilevel model is not only convenient to handle data with hierarchical structures,but also more flexible than traditional methods such as repeated-measurements ANOVA. CONCLUSION: Multilevel Poisson regression model could be used in the analysis of counting data from crossover clinical designs.
    Effects of tegaserod on dyspeptic symptoms, electrogastrography, gastrointestinal transit and anorectal function in chronic constipation
    LI Cui-ping, LIU Shi, XIE Xiao-ping, HOU Xiao-hua
    2007, 12(11):  1311-1316. 
    Asbtract ( 80 )   PDF (232KB) ( 109 )  
    References | Related Articles | Metrics
    AIM: To assessment the effects of tegaserod 6 mg Bid on dyspeptic symptoms, electrogastrography, gastrointestinal transit and anorectal function in chronic constipation (CC). METHODS: The study consisted of a 2-week baseline period, a 4-week randomized, double-blind treatment period with tegaserod 6 mg Bid or placebo. The treatment was conducted in 43 patients with CC and symptoms of dyspepsia. Dyspeptic symptoms, gastric myoelectrical activity, gastrointestinal transit and anorectal function were evaluated before and after treatment of tegaserod or placebo. RESULTS: In comparison with placebo, ①total dyspeptic symptom scores in patients of CC treated with tegaserod 6mg Bid for 4 weeks were lower than before(11.57±3.24 vs 5.29±1.18, P =0.024); ②Tegaserod decreased normal percentages of postprandial electrogastroactivity (6.58 %±1.29 % vs 11.80 %±3.85 %, P =0.044); ③Tegaserod 6 mg Bid significantly accelerated markers in stomach(5.95±1.65 vs 4.57±1.65, P =0.036) and decreased those in the colon(7.50±2.02 vs 5.89±1.94, P =0.029); ④Tegaserod 6 mg Bid significantly decreased the sensation of defecation volume [(25.2±1.8) mm Hg vs (22.9±2.0) mm Hg, P =0.028] and maximal tolerable volume [(32.1±2.5) mm Hg vs (29.3±2.3) mm Hg, P = 0.043]; ⑤ There was no significant difference in the first sensation volume, rectal resting pressure, anal resting pressure andmaximal squeezing pressure after tegaserod treatment(P>0.05). CONCLUSION: Tegaserod 6 mg Bid for 4 weeks may relieve dyspeptic symptoms, significantly accelerate gastrointestinal transit and improve postprandial electrogastroactivity, and decrease the sensation of defecation volume and maximal tolerable volume in patients with with CC.
    Efficiency and safety of Fraxiparin for patients with acute coronary syndrome
    YAN Yu-xiang, LI Jing, GUO mei, LIU Deng-xian
    2007, 12(11):  1317-1320. 
    Asbtract ( 66 )   PDF (164KB) ( 88 )  
    References | Related Articles | Metrics
    AIM: To evaluate the efficiency and safety of Fraxiparin for patients with acute coronary syndrome (ACS). METHODS: 137 patients with ACS were randomly assigned to Fraxiparin treatment or enoxaparin treatment for seven days. RESULTS: 129 cases completed the whole trial and the results were obtained from ITT. The heart death rate is not statistically different between the two groups during the treatment. There are no Q segment acute myocardial infarction happened. Both drugs statistically decreased CK, CKMB and TnT, There was no significant difference between the two groups regarding these changes. Only two minor adverse reactions happened and became normal soon after Nadroparin withdrew. CONCLUSION: Fraxiparin and enoxaparin have similar efficiency and safety in the treatment of patients with ACS.